Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Techstars KC alum Grit Virtual posts $840K oversubscribed seed round
Reality is starting to sink in for Grit Virtual, said co-founder Chris Callen. “It’s exciting to finally be able to talk about our funding rounds and the successes we have had,” Callen said. “It’s been an exciting ride so far, and we’re kind of gearing up to make it a real company, not just an R&D…
State of Entrepreneurship Address: Redefine ‘entrepreneur’ through inclusion
Entrepreneurship rates are half of what they were a generation ago, and although the U.S. population is increasingly diverse, educated and older, the nation’s entrepreneurial population isn’t changing at the same pace, Wendy Guillies said. Founders face too many barriers, said Guillies, president and chief executive officer of the Ewing Marion Kauffman Foundation, Wednesday morning…
Photos: Innovation Exchange returns with Top KC Startups to Watch celebration
So … What’s your spirit animal? Eleven startup founders and leaders joined Startland News and the Kansas City Startup Foundation on stage Tuesday for a rebooted Innovation Exchange experience — complete with casual conversation, jazz and few unexpected queries. Saluting the Top Kansas City Startups to Watch in 2018, the rapid-fire, Q&A-style event showcased the…
City gave into fear, failed the test on innovation with Airbnb vote, councilman says
Kansas City’s move Thursday to prohibit short-term rentals in large portions of the city sent a clear message to entrepreneurs with disruptive ideas and technology, Quinton Lucas said: “Not In My Backyard.” “I don’t know why a city that has so many innovators and that’s buzzing, that’s exciting — and frankly doesn’t always have…